Epitope mapping of anti-drug antibodies to a clinical candidate bispecific antibody

References

• Boehncke W-H, Brembilla NC. Immunogenicity of biologic therapies: causes and consequences. Expert Rev Clin Immunol. 2018;14(6):513–6. doi:10.1080/1744666X.2018.1468753.
   PubMed Web of Science ®Google Scholar
• Garcês S, Demengeot J. The immunogenicity of biologic therapies. Curr Probl Dermatol. 2017;53:37–48.
   PubMedGoogle Scholar
• Sethu S, Govindappa K, Alhaidari M, Pirmohamed M, Park K, Sathish J. Immunogenicity to biologics: mechanisms, prediction and reduction. Arch Immunol Ther Exp (Warsz). 2012;60(5):331–44. doi:10.1007/s00005-012-0189-7.
   PubMed Web of Science ®Google Scholar
• Strand V, Balsa A, Al-Saleh J, Barile-Fabris L, Horiuchi T, Takeuchi T, Lula S, Hawes C, Kola B, Marshall L, et al. Immunogenicity of biologics in chronic inflammatory diseases: a systematic review. BioDrugs. 2017;31(4):299–316. doi:10.1007/s40259-017-0231-8.
   PubMed Web of Science ®Google Scholar
• van Schouwenburg PA, van de Stadt LA, de Jong RN, van Buren EEL, Kruithof S, de Groot E, Hart M, van Ham SM, Rispens T, Aarden L, et al. Adalimumab elicits a restricted anti-idiotypic antibody response in autoimmune patients resulting in functional neutralisation. Ann Rheum Dis. 2013;72(1):104. doi:10.1136/annrheumdis-2012-201445.
   PubMed Web of Science ®Google Scholar
• Harding FA, Stickler MM, Razo J, DuBridge RB. The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regions. MAbs. 2010;2(3):256–65. doi:10.4161/mabs.2.3.11641.
   PubMed Web of Science ®Google Scholar
• Cohen S, Chung S, Spiess C, Lundin V, Stefanich E, Laing ST, Clark V, Brumm J, Zhou Y, Huang C, et al. An integrated approach for characterizing immunogenic responses toward a bispecific antibody. MAbs. 2021;13(1):1944017. doi:10.1080/19420862.2021.1944017.
   PubMed Web of Science ®Google Scholar
• Ridgway JBB, Presta LG, Carter P. ‘Knobs-into-holes’ engineering of antibody CH3 domains for heavy chain heterodimerization. Protein Engineering, Design and Selection. 1996;9(7):617–21. doi:10.1093/protein/9.7.617.
   Google Scholar
• Peng K, Siradze K, Fischer SK. Characterization of robust immune responses to a bispecific antibody, a novel class of antibody therapeutics. Bioanalysis. 2021;13(4):239–52. doi:10.4155/bio-2020-0281.
   PubMed Web of Science ®Google Scholar
• Nilvebrant J, Rockberg J. An introduction to epitope mapping. Methods Mol Biol. 2018;1785:1–10.
   PubMedGoogle Scholar
• Zhang H, Cui W, Gross ML. Mass spectrometry for the biophysical characterization of therapeutic monoclonal antibodies. FEBS Lett. 2014;588(2):308–17. doi:10.1016/j.febslet.2013.11.027.
   PubMed Web of Science ®Google Scholar
• Limpikirati P, Liu T, Vachet RW. Covalent labeling-mass spectrometry with non-specific reagents for studying protein structure and interactions. Methods. 2018;144:79–93. doi:10.1016/j.ymeth.2018.04.002.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wecksler AT, Molina P, Deperalta G, Gross ML. Mapping the binding interface of VEGF and a monoclonal antibody Fab-1 fragment with Fast Photochemical Oxidation of Proteins (FPOP) and mass spectrometry. J Am Soc Mass Spectrom. 2017;28(5):850–58. doi:10.1007/s13361-017-1601-7.
   PubMed Web of Science ®Google Scholar
• Wang L, Chance MR. Structural mass spectrometry of proteins using hydroxyl radical based protein footprinting. Anal Chem. 2011;83(19):7234–41. doi:10.1021/ac200567u.
   PubMed Web of Science ®Google Scholar
• Yan Y, Chen G, Wei H, Huang RY, Mo J, Rempel DL, Tymiak AA, Gross ML. Fast photochemical oxidation of proteins (FPOP) maps the epitope of EGFR binding to adnectin. J Am Soc Mass Spectrom. 2014;25(12):2084–92. doi:10.1007/s13361-014-0993-x.
   PubMed Web of Science ®Google Scholar
• Lin M, Krawitz D, Callahan MD, Deperalta G, Wecksler AT. Characterization of ELISA antibody-antigen interaction using footprinting-mass spectrometry and negative staining transmission electron microscopy. J Am Soc Mass Spectrom. 2018;29(5):961–71. doi:10.1007/s13361-017-1883-9.
   PubMed Web of Science ®Google Scholar
• Ständer S,R, Grauslund L, Scarselli M, Norais N, Rand K. Epitope mapping of polyclonal antibodies by Hydrogen–Deuterium Exchange Mass Spectrometry (HDX-MS). Anal Chem. 2021;93(34):11669–78. doi:10.1021/acs.analchem.1c00696.
   PubMed Web of Science ®Google Scholar
• Li J, Chen G. The use of fast photochemical oxidation of proteins coupled with mass spectrometry in protein therapeutics discovery and development. Drug Discov Today. 2019;24(3):829–34. doi:10.1016/j.drudis.2018.12.008.
   PubMed Web of Science ®Google Scholar
• Liu XR, Rempel DL, Gross ML. Protein higher-order-structure determination by fast photochemical oxidation of proteins and mass spectrometry analysis. Nat Protoc. 2020;15(12):3942–70. doi:10.1038/s41596-020-0396-3.
   PubMed Web of Science ®Google Scholar
• Johnson DT, Di Stefano LH, Jones LM. Fast photochemical oxidation of proteins (FPOP): a powerful mass spectrometry-based structural proteomics tool. J Biol Chem. 2019;294(32):11969–79. doi:10.1074/jbc.REV119.006218.
   PubMed Web of Science ®Google Scholar
• Cornwell O, Radford SE, Ashcroft AE, Ault JR. Comparing hydrogen deuterium exchange and fast photochemical oxidation of proteins: a structural characterisation of wild-type and ΔN6 β2-microglobulin. J Am Soc Mass Spectrom. 2018;29(12):2413–26. doi:10.1007/s13361-018-2067-y.
   PubMed Web of Science ®Google Scholar
• Li KS, Schaper Bergman ET, Beno BR, Huang RY, Deyanova E, Chen G, Gross ML. Hydrogen-deuterium exchange and hydroxyl radical footprinting for mapping hydrophobic interactions of human bromodomain with a small molecule inhibitor. J Am Soc Mass Spectrom. 2019;30(12):2795–804. doi:10.1007/s13361-019-02316-1.
   PubMed Web of Science ®Google Scholar
• Shi L, Liu T, Gross ML, Huang Y. Recognition of human IgG1 by Fcγ receptors: structural insights from hydrogen–deuterium exchange and fast photochemical oxidation of proteins coupled with mass spectrometry. Biochemistry. 2019;58(8):1074–80. doi:10.1021/acs.biochem.8b01048.
   PubMed Web of Science ®Google Scholar
• Charvatova O, Foley BL, Bern MW, Sharp JS, Orlando R, Woods RJ. Quantifying protein interface footprinting by hydroxyl radical oxidation and molecular dynamics simulation: application to galectin-1. J Am Soc Mass Spectrom. 2008;19(11):1692–705. doi:10.1016/j.jasms.2008.07.013.
   PubMed Web of Science ®Google Scholar
• Xie B, Sood A, Woods RJ, Sharp JS. Quantitative protein topography measurements by high resolution hydroxyl radical protein footprinting enable accurate molecular model selection. Sci Rep. 2017;7(1):4552. doi:10.1038/s41598-017-04689-3.
   PubMedGoogle Scholar